摘要
本文综述了现实歪曲、解体、精神运动贫乏三个综合征的家系研究及分子遗传学研究进展,以探讨其作为精神分裂症基因研究的有效表型的可能性。
出处
《国际精神病学杂志》
2010年第1期13-15,共3页
Journal Of International Psychiatry
参考文献15
-
1Toulopoulou T, Picchioni M, Rijsdijk F, et al. Substantial genetic overlap between neuroeognition and schizophrenia. Arch Gen Psyehiatry, 2007; 64: 1348-1355.
-
2Jablensky A. Subtyping schlzophrema: implications for genetic research. Mol Psychiatry, 2006; 11: 815-836.
-
3Torgersen S, Edvardsen J, Oien PA, et al. Schizotypal personality disorder inside and outside the schizophrenic spectrum. Schizophr Res. 2002 ; 54 : 33-38.
-
4Cardno AG, Sham PC, Murray RM, et al. Twin study of symptom dimensions in psychoses. Br J psychiatry, 2001; 179: 39-45.
-
5Rietkerk T, Boks MP, Sommer IE, et al. The genetics of symptom dimensions of schizophrenia : review and meta-analysis. Schizophrenia Research, 2008; 102 ( 1-3 ): 197-205.
-
6Rosa A, Fananas L, Cuesta MJ, et al lq21-q22 locus is associated with susceptibility to the reality-distortion syndrome of schizophrenia spectrum disorders. Am J Med Genet, 2002; 114: 516-518.
-
7Wilcox MA, Faraone SV, Su J, at al. Genome scan of three quantitative traits in schizophrenia pedigrees. Biol Psychiatry, 2002 ; 52: 847-854.
-
8Derosse P, Hodgkinson CA, Lencz T, et al. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry, 2006; 61 (10): 1208-1210.
-
9Serretti A, Lattuada E, Lorenzi C, et al. Dopamine receptor D2 Ser/Cys 311 variant is associated withdelusion and disorganization symptomatology in major psychoses. Mol. Psychiatry, 2000; 5:270-274.
-
10Derosse P, Funke B, Burdick KE, et al. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry, 2006; 163, 532-534.
同被引文献6
-
1向云.精神分裂症与认知功能障碍[J].中国行为医学科学,2005,14(7):620-622. 被引量：66
-
2Nuechterlein KH,Batch DM,Gold JM,et al.Identification of separable cognitive factors in schizophrenia[J].Schizophr Res,2004,72:29-39.
-
3Buchanan RW,Davis M,Golf D,et al.A Summary of the FDA--NIMH--MAT--RICS workshop on clinical trail designs for neurocognitive drugs for schizophrenia[J].Schizophr Bull,2005,31:5.
-
4Reichenberg A,Weiser M,Caspi A,et al.Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders[J].J Clin Exp Neuropsychol,2006,28:193-207.
-
5仇爱玫,李龙飞,李遵清.认知行为疗法对男性精神分裂症患者的康复效果[J].国际护理学杂志,2009,28(9):1239-1242. 被引量：1
-
6王树宁,张永东,殷军波.精神分裂症患者认知康复治疗的研究进展[J].精神医学杂志,2011,24(3):238-240. 被引量：7
-
1孙红梅.奥氮平与精神分裂症患者血脂水平的临床观察[J].中国实用医药,2010,5(32):102-103. 被引量：3
-
2李晓.妄想:被歪曲了的信念[J].心理与健康,2006(12):18-19.
-
3杨国珍,张金红.认知行为疗法对精神分裂阴性症状的影响[J].齐鲁护理杂志,2006,12(05A):823-824. 被引量：2
-
4崔才三,李现亮.运动障碍疾病的诊断及治疗研究概况[J].山东医药,2005,45(1):58-59.
-
5毕崇波,夏文娟,纪军军,赵建军,刘帅.奥氮平和利培酮治疗老年期精神障碍患者疗效对比[J].中国老年学杂志,2013,33(10):2435-2436. 被引量：22
-
6成林平.老年痴呆伴发抑郁症状的相关因素分析[J].广东医学,2006,27(1):57-58. 被引量：13
-
7李新胜,吴江,孔庆根.惊恐障碍的临床表现与治疗策略[J].医药导报,2000,19(4):321-322.
-
8王龙书.奥氮平联合文拉法辛治疗慢性精神分裂症阴性症状对照研究[J].兵团医学,2010(1):1-2. 被引量：2
-
9朱培俊,张静,徐松泉.儿童精神分裂症临床特征分析[J].健康心理学杂志,2000,8(4):367-370.
-
10王珂,谢文煌,王新强.促红细胞生成素对癫痫大鼠神经元的保护作用[J].中国神经免疫学和神经病学杂志,2007,14(4):235-235.
